Actively Recruiting
Compuls-BED-Severity
Led by Laval University · Updated on 2024-10-09
200
Participants Needed
2
Research Sites
147 weeks
Total Duration
On this page
Sponsors
L
Laval University
Lead Sponsor
I
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Collaborating Sponsor
AI-Summary
What this Trial Is About
* Binge Eating Disorder (BED) has been fairly recently introduced into the Diagnostic and Statistical Manual 5 psychiatric classification and its severity criteria are still not well established. * Moreover, it remains unclear whether BED is associated with greater metabolic severity or more somatic comorbidities, especially in obesity. * Improved BED severity staging could lead to a better definition of management strategies and , therefore, facilitate screening and care. The investigators' hypothesis is that an improved assessment of the impulsivity-compulsivity spectrum, emotional regulation, attentional impairment and somatic or psychiatric comorbidities will result in a better distinction between the severe form of BED (e.g., highly impulsive and somatically complicated) from milder form (e.g., more compulsive and less somatically complicated).
CONDITIONS
Official Title
Compuls-BED-Severity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men or women aged 18 to 65 years
- Eligible for bariatric surgery (BMI greater than 40, or BMI greater than 35 with severe comorbidities)
- Scheduled for medical evaluation and treatment of obesity at the IUCPQ Obesity Clinic with BMI 30 or higher
- Scheduled for evaluation and treatment of BED with obesity (BMI 30 or higher) at the CEPIA
- For BED group: positive BEDS-7 screening and Binge Eating Scale score over 16
- For control group: negative BEDS-7 screening and Binge Eating Scale score less than 12
- Fluent in French and able to consent
You will not qualify if you...
- Severe neurological disorder or major neurocognitive deficits
- Previous bariatric surgery or change in anti-obesity medication (liraglutide or naltrexone/bupropion) in the past 3 months
- Unable to read or understand French
- Under guardianship or curatorship
- Already participating in a conflicting study
- Inability to use a computer or iPad
- No access to Internet or inability to visit inclusion sites
- Discordant results between BEDS-7 and Binge Eating Scale (score 16 or below)
- Did not complete parts of assessments or have over 10% missing data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Centre d'expertise Poids, Image et Alimentation (CEPIA)
Québec, Canada
Not Yet Recruiting
2
IUCPQ
Québec, Canada
Actively Recruiting
Research Team
S
Sylvain Iceta, MD, PhD
CONTACT
P
Pelletier Melissa
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here